Two Types of Anti-progestins Have Distinct Effects on Site-specific Phosphorylation of Human Progesterone Receptor
Authors:
Open Access
- 1 January 1996
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (2) , 1209-1217
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- 1,25-Dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylationBiochemistry, 1994
- Steroid hormone receptor phosphorylation: is there a physiological role?Molecular and Cellular Endocrinology, 1994
- Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptorBiochemical Journal, 1993
- Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerizationThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Properties of a purified estradiol-dependent calf uterus tyrosine kinaseBiochemistry, 1993
- Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding.Proceedings of the National Academy of Sciences, 1992
- The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptorCell, 1992
- Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cellsNucleic Acids Research, 1991
- Human Progesterone Receptor Complexed with the Antagonist RU 486 Binds to Hormone Response Elements in a Structurally Altered FormMolecular Endocrinology, 1989
- Phosphotryptic Peptide Analysis of Human Progesterone ReceptorsJournal of Biological Chemistry, 1989